期刊文献+

联合检测外周血胃泌素17及胸苷激酶1水平对胃癌的临床诊断价值分析 被引量:9

Clinical value of serum G17 and TK1 combined detection in the diagnosis of gastric cancer
下载PDF
导出
摘要 目的探讨血清胃泌素17(G17)、胸苷激酶1(TK1)联合检测在胃癌中的临床诊断价值。方法选取徐州市肿瘤医院2016年1月-2016年5月收治的112例胃部疾病患者,按照其病变类型纳入胃癌组(n=46)、胃溃疡组(n=34)、慢性胃炎组(n=32),并选取同期28例健康体检者纳入健康组。分别采用ELISA法和化学发光结合斑点杂交技术检测受试者血清中G17、TK1的含量,并进行组间比较。结果胃癌组血清G17、TK1水平高于健康组、慢性胃炎组和胃溃疡组,差异有统计学意义(P<0.05)。与单独检测G17和TK1比较,联合检测G17和TK1的敏感性明显升高,差异有统计学意义(P<0.05),特异性无明显变化(P>0.05)。结论单项肿瘤标志物检测在胃癌的诊断中应用价值有限,G17和TK1联合检测有助于提高胃癌的诊断性能和早期检出率,有助于胃癌和其他胃部疾病的鉴别诊断。 Objective To evaluate the clinical value of serum Gastrin-17 (G17) and Thymidine kinase-1 (TK1) combined detection in the diagnosis of gastric cancer. Methods One hundred and twelve patients were selected with gastric diseases in our hospital from Jan. 2016 to May. 2016. According to the pathological types, the subjects were di- vided into gastric cancer group ( n = 46) , gastric ulcer group ( n = 34) and chronic superficial gastritis (CSG) group ( n = 32). Meanwhile, 28 healthy subjects were selected as the healthy group. The ELISA and Chemiluminescence combined with Dot Blot Hybridization were used to detect the serum levels of G17, TK1 in all the subjects. Results The levels of G17, TK1 in patients with gastric cancer were significantly higher than those in patients with gastric ulcer, chronic superficial gastritis and healthy subjects (P 〈 0.05). The sensitivity predictive value of combined detection of G17 and TK1 was significantly higher than single detection. Conclusion The clinical value of single detection in the diagnosis of gastric cancer is limited. The combined detection of G17 and TK1 is beneficial to improve the diagnosis performance as well as to increase the diagnostic rate for gastric cancer.
出处 《胃肠病学和肝病学杂志》 CAS 2016年第11期1241-1243,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 胃癌 血清胃泌素17 胸腺激素1 联合检测 Gastric cancer Serum Gastrin-17 Thymidine kinase-1 Combined detection
  • 相关文献

参考文献3

二级参考文献54

  • 1付昕,韩杰,李宁,刘兆云,张继惠.血清肿瘤标志物联合检测对胃癌早期诊断的价值[J].医学检验与临床,2010(4):82-84. 被引量:5
  • 2万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 3AA Guskova, AV Zagurny, Myu Skoblov, et al. Skoblov Molecular Genetic Analysis of Thymidine Kinase of the Herpes Simplex Virus Type l[J].Molecular Biology, 2005,39(1): 137-140.
  • 4He E, Xu XH, Guan H, et al. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast,lung, and esophageal cancer and non-Hodgkin's lymphoma[J]. Nucleosides Nucleotides Nucleic Acids, 2010,29(4-6) : 352- 358.
  • 5Nisman B, Allweis T, Kaduri L, et al. Serum thymidine kinase 1 activity in breast cancer[J].Cancer Biomark,2010,7(2):65 -72.
  • 6He Q, Fornander T, Johansson H, et al. Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer[J]. Anticancer Res, 2006,26(6C) :4753-4759.
  • 7He Q, Zhang P, Zou L, et al. Concentration of thymidine kinase 1 in serum(S-TK1) is a more sensitive proSferation marker in human solid tumors than its activity[J].Oncol Rep,2005,14(4):1 013-1019.
  • 8Kidd EA, Yu J, Li X, etal. Variance in the expression of 5-Fluorouracil pathway genes in colorectal cancer[J]. Clin Cancer Res, 2005 , 11 (7): 2612-2619.
  • 9L Zou, PG Zhang, S Zou, et al. The half-life of thymidine kinase 1 in serum measured by ECL dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer[J].The international Journal of biological Markers,2002, 17( 2): 135-140.
  • 10Chen Y, Ying M, Chert Y, et al. Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings[J].Int J Clin Oncol,2010,15(4):359-368.

共引文献67

同被引文献90

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部